Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Rises By 262.4%

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 1,600,000 shares, an increase of 262.4% from the October 15th total of 441,500 shares. Based on an average trading volume of 30,810,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 3.9% of the shares of the company are sold short.

CERo Therapeutics Price Performance

CERO traded up $0.07 during trading hours on Tuesday, reaching $0.27. 768,953,141 shares of the company’s stock traded hands, compared to its average volume of 15,047,924. The firm has a 50-day moving average price of $0.09 and a 200 day moving average price of $0.38. CERo Therapeutics has a 52-week low of $0.06 and a 52-week high of $12.80.

CERo Therapeutics (NASDAQ:CERO) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.33) EPS for the quarter.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.